# Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid Arthritis

> **NCT01299961** · PHASE3 · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 25 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** abatacept

## Key facts

- **NCT ID:** NCT01299961
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2013-02
- **Final completion:** 2015-02
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2015-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01299961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01299961, "Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01299961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*